The effects of cardiac glycosides and their interaction with catecholamines on glycolysis and glycogenolysis in skeletal muscle.
D000227:Adenine Nucleotides / Q000378:metabolism; D000818:Animals; D002247:Carbon Isotopes; D000242:Cyclic AMP; D003964:Diaphragm; D004074:Digitoxin / Q000494:pharmacology*; D004837:Epinephrine / Q000494:pharmacology; D005943:Gluconeogenesis / Q000187:drug effects*; D005947:Glucose / Q000378:metabolism*; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects*; D006600:Hexosephosphates / Q000378:metabolism; D007773:Lactates / Q000096:biosynthesis; D008297:Male; D009132:Muscles / Q000378:metabolism*; D009638:Norepinephrine / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology*; D010101:Oxygen Consumption / Q000187:drug effects; D011773:Pyruvates / Q000096:biosynthesis; D051381:Rats
D000227:Adenine Nucleotides; D002247:Carbon Isotopes; D006600:Hexosephosphates; D007773:Lactates; D011773:Pyruvates; D010042:Ouabain; D000242:Cyclic AMP; D004074:Digitoxin; D005954:Glucosephosphate Dehydrogenase; D005947:Glucose; D009638:Norepinephrine; D004837:Epinephrine